đź“‹ FDA Reference
ipag micronova interface 781111
Robinton
Summary: The ipag micronova interface 781111 is a medical device used for tumor ablation. It is typically utilized by oncologists and surgeons in various clinical settings to treat patients with specific tumor types.
FDA Clearance Information
Pathway
510K
Number
K791753 ↗
Decision Date
October 2, 1979
Product Code
DXG
Device Class
Class 2
Evidence
0 studies
The ipag micronova interface 781111, manufactured by Robinton, was cleared by the FDA through the 510k pathway on October 2, 1979. It is classified as a Class 2 device under product code DXG.
What It Is
The ipag micronova interface 781111 is an ablation device designed to treat tumors. It works by delivering energy to the targeted tissue, causing thermal destruction of tumor cells. This device is part of a broader category of minimally invasive tools that offer a therapeutic option for patients who may not be candidates for traditional surgery.
Clinical Applications
This device is commonly used in oncology and surgical settings for the ablation of tumors. It is particularly useful in treating patients with localized tumors where surgical resection is not feasible. The device is often employed in outpatient or hospital settings, providing a less invasive alternative to open surgery for certain patient populations.
Indications for Use
The ipag micronova interface 781111 is indicated for use in patients with certain types of tumors that are amenable to ablation therapy. It is suitable for patients who require targeted treatment of tumor tissues, especially when other treatment options are limited.
Practical Considerations
Clinicians should consider the size and location of the tumor when selecting this device. Compatibility with existing imaging and surgical systems should be verified to ensure optimal outcomes. Proper technique and training are essential for effective use and to minimize potential complications.
Frequently Asked Questions
What is ipag micronova interface 781111 used for?
It is used for the ablation of tumors, providing a minimally invasive treatment option for certain cancer patients.
What specialties typically use this device?
Oncology and surgical specialties commonly use this device, particularly in settings focused on tumor treatment.
What are the FDA-cleared indications?
The device is indicated for the ablation of tumors, offering a treatment option for patients with specific tumor types.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.